GSA CAPITAL PARTNERS LLP - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 39 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$71,000
-89.6%
48,923
-81.0%
0.01%
-87.1%
Q3 2021$683,000
+7.9%
257,684
+61.3%
0.07%
-1.4%
Q2 2021$633,000159,7310.07%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 732,135$1,940,0000.83%
Green Alpha Advisors, LLC 61,759$164,0000.11%
Values First Advisors, Inc. 49,179$130,0000.08%
GSA CAPITAL PARTNERS LLP 257,684$683,0000.07%
SHELTON CAPITAL MANAGEMENT 240,000$636,0000.02%
Walleye Capital LLC 154,997$411,0000.01%
PDT Partners, LLC 59,400$157,0000.01%
Archford Capital Strategies, LLC 13,091$35,0000.01%
Susquehanna International Group Ltd. 13,164$35,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$444,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders